|
105 Companies |
|
193 Products |
|
193 Products |
|
133 Mechanisms of Action |
|
26 Trials |
|
4426 News |
|
| «12...56789101112131415...8990» |
- | Trial completion, Phase classification, Enrollment change, Trial primary completion date: Ultrasound-guided Intermediate Cervical Plexus Block (clinicaltrials.gov) - Aug 21, 2017
P=N/A, N=30, Completed, Sponsor: Helios Research Center
Recruiting --> Completed | Phase classification: P4 --> PN/A | N=60 --> 30 | Trial primary completion date: Dec 2017 --> Aug 2017
- ||| warfarin / Generic mfg.
Enrollment closed, Enrollment change: Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study (clinicaltrials.gov) - Aug 18, 2017
P4, N=692, Active, not recruiting, Sponsor: Satoshi Shizuta
Recruiting --> Completed | Phase classification: P4 --> PN/A | N=60 --> 30 | Trial primary completion date: Dec 2017 --> Aug 2017 Recruiting --> Active, not recruiting | N=2000 --> 692
- | Enrollment change: ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System (clinicaltrials.gov) - Aug 18, 2017
P=N/A, N=39, Terminated, Sponsor: Frank Saltiel
Recruiting --> Active, not recruiting | N=2000 --> 692 N=52 --> 39
- | Enrollment change: To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease (clinicaltrials.gov) - Aug 18, 2017
P2a, N=48, Completed, Sponsor: MedImmune LLC
N=52 --> 39 N=230 --> 48
- Trial termination: STRONG: Data Registry Following Patients Using Supera Stent in the Femoral Arteries (clinicaltrials.gov) - Aug 17, 2017
P=N/A, N=200, Terminated, Sponsor: Abbott Vascular
N=230 --> 48 Active, not recruiting --> Terminated; Slow enrollment,increased loss to follow-ups and general lack of interest.
- | niacin extended-release formulation / Generic mfg.
Trial completion, Enrollment change: ALPINE-SVG: Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis (clinicaltrials.gov) - Aug 17, 2017
P2, N=38, Completed, Sponsor: North Texas Veterans Healthcare System
Active, not recruiting --> Terminated; Slow enrollment,increased loss to follow-ups and general lack of interest. Active, not recruiting --> Completed | N=138 --> 38
- | Trial completion, Phase classification, Trial primary completion date: Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study (clinicaltrials.gov) - Aug 17, 2017
P=N/A, N=10, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed | N=138 --> 38 Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial primary completion date: Jan 2011 --> Jun 2010
- | Exparel (bupivacaine liposome injectable suspension) / Pacira
Trial completion, Surgery: Parasternal Nerve Block in Cardiac Patients (clinicaltrials.gov) - Aug 17, 2017
P2, N=78, Completed, Sponsor: Peter A Knight
Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial primary completion date: Jan 2011 --> Jun 2010 Active, not recruiting --> Completed
- | Enrollment change: Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease (clinicaltrials.gov) - Aug 17, 2017
P2a, N=32, Recruiting, Sponsor: MedImmune LLC
Active, not recruiting --> Completed N=24 --> 32
- | ticagrelor / Generic mfg.
Trial completion, Enrollment change: Reversal of the Anti-platelet Effects of Ticagrelor (clinicaltrials.gov) - Aug 16, 2017
P4, N=64, Completed, Sponsor: The First Affiliated Hospital with Nanjing Medical University
N=24 --> 32 Recruiting --> Completed | N=48 --> 64
- | ranolazine ER / Generic mfg.
Trial termination: STERILE: Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities (clinicaltrials.gov) - Aug 9, 2017
P=N/A, N=29, Terminated, Sponsor: William Beaumont Hospitals
Recruiting --> Completed | N=48 --> 64 Completed --> Terminated
- | Trial completion, Enrollment change, Trial primary completion date: The Prevalence of Radial Artery Occlusion in Diagnostic Cardiac Catheterization and Percutaneous Intervention (clinicaltrials.gov) - Aug 9, 2017
P=N/A, N=172, Completed, Sponsor: Jesse Brown VA Medical Center
Completed --> Terminated Recruiting --> Completed | N=300 --> 172 | Trial primary completion date: Jul 2016 --> Jul 2017
- | Enrollment change: Effects of Zortress (clinicaltrials.gov) - Aug 7, 2017
P=N/A, N=0, Withdrawn, Sponsor: University of Kentucky
Recruiting --> Completed | N=300 --> 172 | Trial primary completion date: Jul 2016 --> Jul 2017 N=60 --> 0
- | autologous mesenchymal stem cells / Mayo Clinic, National Institute of Neurological Disorders and Stroke
Trial completion: MSC for Occlusive Disease of the Kidney (clinicaltrials.gov) - Aug 7, 2017
P1, N=6, Completed, Sponsor: Mayo Clinic
N=60 --> 0 Active, not recruiting --> Completed
- | Xience (everolimus-eluting stent) / Abbott
Trial primary completion date: ORSIRO_OCT: ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography (clinicaltrials.gov) - Aug 4, 2017
P4, N=30, Completed, Sponsor: Deutsches Herzzentrum Muenchen
Active, not recruiting --> Completed Trial primary completion date: Sep 2013 --> Jun 2013
- ||| Zontivity (vorapaxar) / Merck (MSD)
Trial initiation date: Vorapaxar and Lower Extremity Bypass Grafts (clinicaltrials.gov) - Aug 4, 2017
P4, N=100, Not yet recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Sep 2013 --> Jun 2013 Initiation date: Dec 2016 --> Aug 2017
- | febuxostat / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia (clinicaltrials.gov) - Aug 3, 2017
P4, N=1, Terminated, Sponsor: Yokohama City University Medical Center
Initiation date: Dec 2016 --> Aug 2017 N=60 --> 1 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2020 --> Mar 2017; Entry were insufficient as expected.
- || Absorb (everolimus-eluting bioresorbable vascular scaffold) / Abbott
Enrollment change, Trial initiation date: ABSORB Post-Approval Clinical Study (clinicaltrials.gov) - Aug 3, 2017
P=N/A, N=2000, Not yet recruiting, Sponsor: Abbott Vascular
N=60 --> 1 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2020 --> Mar 2017; Entry were insufficient as expected. N=3000 --> 2000 | Initiation date: Nov 2016 --> Aug 2017
- Enrollment closed: REALITY III: Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System (clinicaltrials.gov) - Aug 3, 2017
P=N/A, N=30, Active, not recruiting, Sponsor: C. R. Bard
N=3000 --> 2000 | Initiation date: Nov 2016 --> Aug 2017 Recruiting --> Active, not recruiting
- ||| Trial completion: Q-CAMP: Non-invasive Computer-Aided Phenotyping of Vasculopathy (clinicaltrials.gov) - Aug 2, 2017
P=N/A, N=128, Completed, Sponsor: Elucid Bioimaging Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial primary completion date: Trial of an Internet-based Platform for Managing Chronic Diseases at a Distance (clinicaltrials.gov) - Aug 1, 2017
P=N/A, N=318, Active, not recruiting, Sponsor: Simon Fraser University
Active, not recruiting --> Completed Trial primary completion date: May 2017 --> Aug 2017
- | Trial primary completion date: a Physician-inititated Trial Investigating the iVolution Nitinol Stent (clinicaltrials.gov) - Aug 1, 2017
P2/3, N=120, Recruiting, Sponsor: Flanders Medical Research Program
Trial primary completion date: May 2017 --> Aug 2017 Trial primary completion date: Jun 2017 --> Jan 2018
- | Trial completion: Clear-Road Trial, Investigating the Efficacy of the RoadSaver Stent (clinicaltrials.gov) - Aug 1, 2017
P2/3, N=100, Completed, Sponsor: Flanders Medical Research Program
Trial primary completion date: Jun 2017 --> Jan 2018 Active, not recruiting --> Completed
- | Trial completion, Trial primary completion date: ROBINSON: Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion (clinicaltrials.gov) - Aug 1, 2017
P4, N=30, Completed, Sponsor: Flanders Medical Research Program
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jun 2016 --> Jan 2017
- ||| Trial completion: MASCOT - Post Marketing Registry (clinicaltrials.gov) - Aug 1, 2017
P=N/A, N=2500, Completed, Sponsor: OrbusNeich
Active, not recruiting --> Completed | Trial primary completion date: Jun 2016 --> Jan 2017 Active, not recruiting --> Completed
- | sevoflurane / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, Surgery: Impact of Variable Types of Preconditioning Upon the Inotrope Score in Adult Patients, Undergoing Cardiac Surgery (clinicaltrials.gov) - Aug 1, 2017
P=N/A, N=60, Completed, Sponsor: Assiut University
Active, not recruiting --> Completed Recruiting --> Completed | N=20 --> 60 | Trial primary completion date: Jul 2017 --> Mar 2017
- ||| Trial completion: Sapphire II PRO US Clinical Study (clinicaltrials.gov) - Jul 31, 2017
P=N/A, N=61, Completed, Sponsor: OrbusNeich
Recruiting --> Completed | N=20 --> 60 | Trial primary completion date: Jul 2017 --> Mar 2017 Recruiting --> Completed
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial initiation date: Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study (clinicaltrials.gov) - Jul 28, 2017
P=N/A, N=75, Active, not recruiting, Sponsor: Medtronic Vascular
Recruiting --> Completed Initiation date: Apr 2015 --> Jul 2015
- | Trial completion: EVAGO: Ocular Discomfort Assessment After Intravitreal Injections (clinicaltrials.gov) - Jul 28, 2017
P=N/A, N=45, Completed, Sponsor: Centre Hospitalier Intercommunal Creteil
Initiation date: Apr 2015 --> Jul 2015 Recruiting --> Completed
- | Trial completion: Vascular Physician Offer and Report (VAPOR) Trial (clinicaltrials.gov) - Jul 27, 2017
P=N/A, N=156, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD (clinicaltrials.gov) - Jul 27, 2017
P=N/A, N=89, Completed, Sponsor: Beijing Anzhen Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=120 --> 89 | Trial primary completion date: Dec 2015 --> Jun 2016
- | Trial completion, Trial primary completion date, Surgery, Stroma: Stem Cell Injection to Treat Heart Damage During Open Heart Surgery (clinicaltrials.gov) - Jul 27, 2017
P1, N=24, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting --> Completed | N=120 --> 89 | Trial primary completion date: Dec 2015 --> Jun 2016 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jul 2017
- || Trial primary completion date: Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up (clinicaltrials.gov) - Jul 27, 2017
P=N/A, N=70, Recruiting, Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jul 2017 Trial primary completion date: May 2017 --> Oct 2017
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment closed, Trial primary completion date: Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies (clinicaltrials.gov) - Jul 26, 2017
P=N/A, N=44, Active, not recruiting, Sponsor: Daniel S. Berman
Trial primary completion date: May 2017 --> Oct 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2017 --> Dec 2018
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion: A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study (clinicaltrials.gov) - Jul 26, 2017
P4, N=60, Completed, Sponsor: The University of Hong Kong
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2017 --> Dec 2018 Active, not recruiting --> Completed
- Trial primary completion date: Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD) (clinicaltrials.gov) - Jul 25, 2017
P=N/A, N=45, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Trial primary completion date: Sep 2017 --> Dec 2017
- | Trial completion, Enrollment change: Comparing Carotid Stenting With Endarterectomy in Severe Asymptomatic Carotid Stenosis (clinicaltrials.gov) - Jul 25, 2017
P4, N=137, Completed, Sponsor: Carmel Medical Center
Trial primary completion date: Sep 2017 --> Dec 2017 Recruiting --> Completed | N=500 --> 137
- || Enrollment change, Trial primary completion date: Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events (clinicaltrials.gov) - Jul 23, 2017
P=N/A, N=66, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed | N=500 --> 137 N=90 --> 66 | Trial primary completion date: Nov 2011 --> May 2012
- ||| Xience (everolimus-eluting stent) / Abbott
Trial completion: Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT ) (clinicaltrials.gov) - Jul 21, 2017
P=N/A, N=3001, Completed, Sponsor: Seung-Jung Park
N=90 --> 66 | Trial primary completion date: Nov 2011 --> May 2012 Active, not recruiting --> Completed
- | Enrollment closed, Surgery: Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass (clinicaltrials.gov) - Jul 21, 2017
P2, N=126, Active, not recruiting, Sponsor: University of Alberta
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- NN1213 / Novo Nordisk
Phase classification: Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I) (clinicaltrials.gov) - Jul 19, 2017
P=N/A, N=1663, Terminated, Sponsor: Abbott Vascular
Recruiting --> Active, not recruiting Phase classification: P3 --> P=N/A
- ||| clopidogrel / Generic mfg.
Trial completion: Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients (clinicaltrials.gov) - Jul 19, 2017
P=N/A, N=1078, Completed, Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Phase classification: P3 --> P=N/A Active, not recruiting --> Completed
- ticagrelor / Generic mfg., aspirin / Generic mfg.
Enrollment change: TI-PAD EVR: Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR (clinicaltrials.gov) - Jul 19, 2017
P2, N=40, Terminated, Sponsor: AstraZeneca
Active, not recruiting --> Completed N=71 --> 40
- | Trial primary completion date: Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT (clinicaltrials.gov) - Jul 19, 2017
P=N/A, N=500, Recruiting, Sponsor: Hospital Universitari Vall d'Hebron Research Institute
N=71 --> 40 Trial primary completion date: Jun 2017 --> Oct 2017
- | ticagrelor / Generic mfg., clopidogrel / Generic mfg.
Trial completion, Trial primary completion date: ALTIC: A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction (clinicaltrials.gov) - Jul 18, 2017
P4, N=20, Completed, Sponsor: University of Patras
Trial primary completion date: Jun 2017 --> Oct 2017 Recruiting --> Completed | Trial primary completion date: Jan 2018 --> Jun 2017
- | minocycline / Generic mfg.
Trial withdrawal: A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy (clinicaltrials.gov) - Jul 17, 2017
P2, N=0, Withdrawn, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed | Trial primary completion date: Jan 2018 --> Jun 2017 Terminated --> Withdrawn
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion: Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET (clinicaltrials.gov) - Jul 13, 2017
P4, N=41, Completed, Sponsor: Brigham and Women's Hospital
Terminated --> Withdrawn Active, not recruiting --> Completed
- |||| acarbose / Generic mfg.
Trial completion: ACE: Acarbose Cardiovascular Evaluation Trial (clinicaltrials.gov) - Jul 11, 2017
P4, N=6526, Completed, Sponsor: University of Oxford
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: MID-EPIC: Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=50, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment open, Enrollment change: Isometric Handgrip Training on Blood Pressure of Peripheral Artery Disease Patients (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=90, Recruiting, Sponsor: University of Pernambuco
Active, not recruiting --> Completed Active, not recruiting --> Recruiting | N=60 --> 90